Escalation to weekly adalimumab for the treatment of ocular Inflammation

dc.contributor.authorLiberman Salazar, Paulina
dc.contributor.authorBerkenstock, M. K.
dc.contributor.authorBurkholder, B. M.
dc.contributor.authorChaon, B. C.
dc.contributor.authorThorne, J. E.
dc.date.accessioned2021-08-13T20:26:25Z
dc.date.available2021-08-13T20:26:25Z
dc.date.issued2020
dc.fuente.origenConveris
dc.identifier.doi10.1080/09273948.2020.1749857
dc.identifier.issn0927-3948
dc.identifier.scopusid2-s2.0-85085045397
dc.identifier.urihttps://doi.org/10.1080/09273948.2020.1749857
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/61921
dc.information.autorucEscuela de Medicina ; Liberman Salazar, Paulina ; 0000-0002-1053-8651 ; 238017
dc.language.isoen
dc.revistaOcular Immunology and Inflammationes_ES
dc.titleEscalation to weekly adalimumab for the treatment of ocular Inflammationes_ES
dc.typeartículo
sipa.codpersvinculados238017
Files